Literature DB >> 10758567

Adenocarcinoma of the Endometrium: An Institutional Review.

.   

Abstract

BACKGROUND: Many oncologists regard endometrial cancer as a relatively benign and easily treatable gynecologic tumor. Inadequate care can result in poor outcomes.
METHODS: The authors review the epidemiology and pathology of the disease, and they compare disease characteristics and outcomes of FIGO staging with their own 11-year experience at a tertiary referral center.
RESULTS: Patients referred to tertiary referral centers tend to present with more advanced stages of disease than those reported by FIGO, although the profile of histologic types is similar.
CONCLUSIONS: Prevention and early detection of endometrial cancer can minimize the impact of this disease. Complete staging and tumor removal including extrafascial hysterectomy with bilateral salpingo-oophorectomy, pelvic lymphadenectomy, and selective paraaortic lymphadenectomy are the cornerstones of surgical therapy.

Entities:  

Year:  1999        PMID: 10758567     DOI: 10.1177/107327489900600405

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  10 in total

1.  Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.

Authors:  Mehmet Coskun Salman; Alp Usubutun; Kubra Boynukalin; Kunter Yuce
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  SKY analysis revealed recurrent numerical and structural chromosome changes in BDII rat endometrial carcinomas.

Authors:  Eva Falck; Carola Hedberg; Karin Klinga-Levan; Afrouz Behboudi
Journal:  Cancer Cell Int       Date:  2011-06-27       Impact factor: 5.722

3.  MicroRNA expression in human endometrial adenocarcinoma.

Authors:  Sanja Jurcevic; Björn Olsson; Karin Klinga-Levan
Journal:  Cancer Cell Int       Date:  2014-11-14       Impact factor: 5.722

Review 4.  Dysregulated expression of long noncoding RNAs in gynecologic cancers.

Authors:  Elahe Seyed Hosseini; Matthieu Meryet-Figuiere; Hamed Sabzalipoor; Hamed Haddad Kashani; Hossein Nikzad; Zatollah Asemi
Journal:  Mol Cancer       Date:  2017-06-21       Impact factor: 27.401

Review 5.  Non-Coding RNAs and Endometrial Cancer.

Authors:  Cristina Vallone; Giuliano Rigon; Caterina Gulia; Alberto Baffa; Raffaella Votino; Giulia Morosetti; Simona Zaami; Vito Briganti; Francesco Catania; Marco Gaffi; Roberto Nucciotti; Fabio Massimo Costantini; Roberto Piergentili; Lorenza Putignani; Fabrizio Signore
Journal:  Genes (Basel)       Date:  2018-03-29       Impact factor: 4.096

6.  Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.

Authors:  Ming-Jun Fan; Shu-Mei Liang; Peng-Juan He; Xing-Bo Zhao; Ming-Jiang Li; Feng Geng
Journal:  Radiol Oncol       Date:  2019-09-24       Impact factor: 2.991

7.  Expression patterns of Phf5a/PHF5A and Gja1/GJA1 in rat and human endometrial cancer.

Authors:  Eva Falck; Karin Klinga-Levan
Journal:  Cancer Cell Int       Date:  2013-05-15       Impact factor: 5.722

8.  Validation of suitable endogenous control genes for quantitative PCR analysis of microRNA gene expression in a rat model of endometrial cancer.

Authors:  Sanja Jurcevic; Björn Olsson; Karin Klinga-Levan
Journal:  Cancer Cell Int       Date:  2013-05-16       Impact factor: 5.722

Review 9.  Long Non-Coding RNAs in Endometrial Carcinoma.

Authors:  Maria A Smolle; Marc D Bullock; Hui Ling; Martin Pichler; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2015-11-04       Impact factor: 5.923

10.  Verification of microRNA expression in human endometrial adenocarcinoma.

Authors:  Sanja Jurcevic; Karin Klinga-Levan; Björn Olsson; Katarina Ejeskär
Journal:  BMC Cancer       Date:  2016-04-02       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.